Intravenous Iron Drugs Market Size, Share, Demand & Trends Analysis Report by 2032
Intravenous Iron Drugs Market by Product (Ferric Carboxymaltose, Iron Sucrose, Iron Dextran, and Others) and Application (Cancer, Inflammatory Bowel Disease, Chronic Kidney Disease, and Other Diseases): Global Industry Perspective, Comprehensive Analysis and Forecast 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.88 Billion | USD 6.00 Billion | 8.5% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Intravenous Iron Drugs Market, 2016–2025 (USD Million)
- 2.2. Intravenous Iron Drugs Market: Snapshot
- Chapter 3. Intravenous Iron Drugs Market – Industry Analysis
- 3.1. Intravenous Iron Drugs Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Increasing incidence of chronic renal disease
- 3.2.2. Increasing geriatric population
- 3.3. Restraints
- 3.3.1. Some side-effects associated with intravenous iron drugs
- 3.3.2. Stringent regulations
- 3.4. Opportunities
- 3.4.1. Development of novel products
- 3.4.2. Growing need for prevention of anemia in pregnant women
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis By Product
- 3.6.2. Market attractiveness analysis By Application
- 3.6.3. Market attractiveness analysis by Region
- Chapter 4. Intravenous Iron Drugs Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Intravenous Iron Drugs Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Intravenous Iron Drugs Market –Product Analysis
- 5.1. Global Intravenous Iron Drugs Market overview: By Product
- 5.1.1. Global Intravenous Iron Drugs Market share, By Product,2018 and 2025
- 5.2. Ferric Carboxymaltose
- 5.2.1. Global Intravenous Iron Drugs Market by Ferric Carboxymaltose, 2016–2025 (USD Million)
- 5.3. Iron Sucrose
- 5.3.1. Global Intravenous Iron Drugs Market by Iron Sucrose, 2016–2025 (USD Million)
- 5.4. Iron Dextran
- 5.4.1. Global Intravenous Iron Drugs Market by Iron Dextran, 2016–2025 (USD Million)
- 5.5. Others
- 5.5.1. Global Intravenous Iron Drugs Market by Others, 2016–2025 (USD Million)
- 5.1. Global Intravenous Iron Drugs Market overview: By Product
- Chapter 6. Global Intravenous Iron Drugs Market –Application Analysis
- 6.1. Global Intravenous Iron Drugs Market overview: By Application
- 6.1.1. Global Intravenous Iron Drugs Market share, By Application, 2018 and 2025
- 6.2. Cancer
- 6.2.1. Global Intravenous Iron Drugs Market By Cancer, 2016–2025 (USD Million)
- 6.3. Inflammatory Bowel Disease
- 6.3.1. Global Intravenous Iron Drugs Market By Inflammatory Bowel Disease, 2016–2025 (USD Million)
- 6.4. Chronic Kidney Disease
- 6.4.1. Global Intravenous Iron Drugs Market By Chronic Kidney Disease, 2016–2025 (USD Million)
- 6.5. Other Diseases
- 6.5.1. Global Intravenous Iron Drugs Market By Other Diseases, 2016–2025 (USD Million)
- 6.1. Global Intravenous Iron Drugs Market overview: By Application
- Chapter 7. Global Intravenous Iron Drugs Market - Regional Analysis
- 7.1. Global Intravenous Iron Drugs Market overview: by Region
- 7.1.1. Global Intravenous Iron Drugs Market share, by Region, 2018 and 2025
- 7.2. North America
- 7.2.1. North America Intravenous Iron Drugs Market, 2016–2025 (USD Million)
- 7.2.2. North America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.2.3. North America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.2.4. U.S.
- 7.2.4.1. U.S. Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.2.4.2. U.S. Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.2.4. U.S.
- 7.2.5. Rest of North America
- 7.2.5.1. Rest of North America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.2.5.2. Rest of North America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Intravenous Iron Drugs Market, 2016–2025 (USD Million)
- 7.3.2. Europe Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.3.3. Europe Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.3.4. UK
- 7.3.4.1. U.K. Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.3.4.2. U.K. Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.3.5. France
- 7.3.5.1. France Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.3.5.2. France Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.3.6. Germany
- 7.3.6.1. Germany Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.3.6.2. Germany Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.3.7. Rest of Europe
- 7.3.7.1. Rest of Europe Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.3.7.2. Rest of Europe Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Intravenous Iron Drugs Market, 2016–2025 (USD Million)
- 7.4.2. Asia Pacific Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.4.3. Asia Pacific Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.4.4. China
- 7.4.4.1. China Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.4.4.2. China Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.4.5. Japan
- 7.4.5.1. Japan Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.4.5.2. Japan Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.4.6. India
- 7.4.6.1. India Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.4.6.2. India Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.4.7. Rest of Asia Pacific
- 7.4.7.1. Rest of Asia Pacific Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.4.7.2. Rest of Asia Pacific Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Intravenous Iron Drugs Market, 2016–2025 (USD Million)
- 7.5.2. Latin America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.5.3. Latin America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.5.4. Brazil
- 7.5.4.1. Brazil Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.5.4.2. Brazil Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.5.5. Rest of Latin America
- 7.5.5.1. Rest of Latin America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.5.5.2. Rest of Latin America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.6. The Middle East and Africa
- 7.6.1. The Middle East and Africa Intravenous Iron Drugs Market, 2016–2025 (USD Million)
- 7.6.2. The Middle East and Africa Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
- 7.6.3. The Middle East and Africa Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
- 7.1. Global Intravenous Iron Drugs Market overview: by Region
- Chapter 8. Company Profiles
- 8.1. Daiichi Sankyo Company, Ltd.
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Allergan, Inc.
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. Sanofi
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Developments
- 8.4. Rockwell Medical Technologies, Inc.
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Developments
- 8.5. Fresenius Medical Care AG & Co.
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. AMAG Pharmaceuticals. Inc.
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Pharmacosmos A/S
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. Vifor Pharma Management Ltd.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. American Regent. Inc.
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.10. Shield Therapeutics Plc
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Product Portfolio
- 8.10.4. Business Strategy
- 8.10.5. Recent Development
- 8.1. Daiichi Sankyo Company, Ltd.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Intravenous Iron Drugs Market, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Intravenous Iron Drugs Market attractiveness, By Product
6. Global Intravenous Iron Drugs Market attractiveness, By Application
7. Global Intravenous Iron Drugs Market attractiveness, By Region
8. Global Intravenous Iron Drugs Market share, By Product, 2018 and 2025
9. Global Intravenous Iron Drugs Market by Ferric Carboxymaltose, 2016–2025 (USD Million)
10. Global Intravenous Iron Drugs Market by Iron Sucrose,2016–2025 (USD Million)
11. Global Intravenous Iron Drugs Market by Iron Dextran,2016–2025 (USD Million)
12. Global Intravenous Iron Drugs Market by Others,2016–2025 (USD Million)
13. Global Intravenous Iron Drugs Market share, By Application, 2018 and 2025
14. Global Intravenous Iron Drugs Market By Cancer , 2016–2025 (USD Million)
15. Global Intravenous Iron Drugs Market By Inflammatory Bowel Disease, 2016–2025 (USD Million)
16. Global Intravenous Iron Drugs Market By Chronic Kidney Disease, 2016–2025 (USD Million)
17. Global Intravenous Iron Drugs Market By Other Diseases, 2016–2025 (USD Million)
18. Global Intravenous Iron Drugs Market share, by Region, 2018and 2025
19. North America Intravenous Iron Drugs Market, 2016–2025 (USD Million)
20. Europe Intravenous Iron Drugs Market, 2016–2025 (USD Million)
21. Asia Pacific Intravenous Iron Drugs Market, 2016–2025 (USD Million)
22. Latin America Intravenous Iron Drugs Market, 2016–2025 (USD Million)
23. The Middle East and Africa Intravenous Iron Drugs Market, 2016–2025 (USD Million)
Table Of Tables
List of Tables
1. Global Intravenous Iron Drugs Market: snapshot
2. Drivers of the Intravenous Iron Drugs Market: impact analysis
3. Restraints of the Intravenous Iron Drugs Market: impact analysis
4. North America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
5. North America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
6. U.S. Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
7. U.S. Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
8. Rest of North America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
9. Rest of North America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
10. Europe Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
11. Europe Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
12. U.K. Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
13. U.K. Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
14. France Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
15. France Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
16. Germany Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
17. Germany Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
18. Rest of Europe Intravenous Iron Drugs revenue, By Product,2016–2025 (USD Million)
19. Rest of Europe Intravenous Iron Drugs revenue, By Application, 2016–2025 (USD Million)
20. Asia Pacific Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
21. Asia Pacific Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
22. China Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
23. China Intravenous Iron Drugs revenue, By Application, 2016–2025 (USD Million)
24. Japan Intravenous Iron Drugs revenue, By Product,2016–2025 (USD Million)
25. Japan Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
26. India Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
27. India Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
28. Rest of Asia Pacific Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
29. Rest of Asia Pacific Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
30. Latin America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
31. Latin America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
32. Brazil Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
33. Brazil Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
34. Rest of Latin America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
35. Rest of Latin America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
36. The Middle East and Africa Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
37. The Middle East and Africa Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
Methodology
FrequentlyAsked Questions
Intravenous iron drugs are used to treat iron deficiency anemia. They deliver iron directly into the bloodstream for faster absorption.
The global intravenous iron drugs market is expected to be driven by the rising anemia prevalence, chronic kidney disease cases, and preference for rapid iron replacement therapies.
According to study, the global intravenous iron drugs market size was worth around USD 2.88 Billion in 2023 and is predicted to grow to around USD 6 Billion By 2032.
The global intravenous iron drugs market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 8.5% during the forecast period from 2024-2032.
The global intravenous iron drugs industry is projected to be challenged by Challenges include safety concerns, infusion reactions, and strict regulatory oversight. Cost, administration logistics, and reimbursement variability impact utilization.
The Opportunities lie in anemia management for chronic kidney disease, oncology, and women’s health. Faster-acting formulations and outpatient infusion growth support adoption will offer significant growth opportunities in the intravenous iron drugs market.
New-generation iron formulations; improved safety and dosing efficiency; growth in anemia management are the emerging trends and innovations impacting the intravenous iron drugs market.
The global intravenous iron drugs market is expected to be led by Europe during the forecast period.
Some of the prominent players operating in the global intravenous iron drugs market are; Daiichi Sankyo Company, Ltd., Allergan, Inc., Sanofi, Rockwell Medical Technologies, Inc., Fresenius Medical Care AG & Co., AMAG Pharmaceuticals. Inc., Pharmacosmos A/S, Vifor Pharma Management Ltd., American Regent. Inc., and Shield Therapeutics Plc among others and others.
The report explores crucial aspects of the intravenous iron drugs market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
